Pathora Bio is building an execution-focused translational pathology CRO for histology, multiplex IHC/IF, digital pathology, biomarker analytics, spatial-ready tissue workflows, and clinical trial support.
Pathora Bio translates advanced tissue science into a clear business problem: fragmented academic and vendor workflows delay tissue biomarker programs for pharma, biotech, and clinical research teams.
Clients lose time when tissue retrieval, pathology review, sectioning, staining, imaging, and analysis are split across disconnected groups.
Positioned as a high-end translational pathology CRO, not a commodity histology lab.
Headquartered in Miami with a scalable model for national and international pharma, biotech, and translational research clients.
The value is simple: faster execution, better tissue biomarker data, accountable delivery, and CRO-grade quality systems.
Flexible specimen intake and end-to-end project ownership for pharma, biotech, and translational oncology teams.
FFPE sectioning, H&E, unstained slides, TMAs, and research-ready tissue preparation.
Targeted biomarker staining, assay optimization, controls, and reproducibility-focused workflows.
RNA/DNA in situ hybridization assay support, including FISH/RNAscope-style workflows and tissue-based molecular localization.
Multiplex IF/IHC and spatial-ready tissue imaging for translational biomarker programs.
Quantitative pathology, segmentation, biomarker scoring, spatial analysis, and report-ready outputs.
One accountable workflow across intake, pathology review, histology, staining, imaging, analysis, and delivery.
Blocks, slides, TMAs, sections, stained slides, WSIs, and de-identified data.
ROI selection, tissue suitability, necrosis, tumor content, and assay feasibility.
Sectioning, H&E, staining controls, panel verification, and tissue-readiness gates.
Whole-slide imaging, multiplex imaging, digital pathology, and biomarker analytics.
Structured deliverables, image files, quantified data, QC notes, and scientific interpretation.
Explore the Pathora Bio interactive workflow platform. On phones, a mobile workflow card appears first; desktop and tablet users see the full widescreen interactive slide workflow.
Visualizes scientific consultation, assay strategy, sample processing, analysis, and secure delivery.
Launch Interactive WorkflowPathora Bio is designed around reproducibility, traceability, QA/QC, regulatory readiness, specimen tracking, SOPs, and CRO-grade documentation.
Clinical laboratory operational standards, QC oversight, specimen traceability, and scalable compliance workflows.
SOP-driven design supporting reproducibility, audit readiness, workflow standardization, and CRO-grade execution.
Accountability, specimen tracking, reporting consistency, operational transparency, and high-end translational pathology workflows.
Pathora Bio is positioned at the intersection of translational pathology, multiplex tissue imaging, digital pathology, biomarker analytics, and clinical trial support.
Thomas Lisse, PhD
NIH-trained translational scientist and director-level translational pathology operator with expertise in histology, multiplex tissue imaging, digital pathology, biomarker analytics, spatial biology, and clinical trial support workflows.
Built from direct experience managing real-world academic cancer center bottlenecks and supporting CAP/CLIA-aligned CRO spatial imaging and genomics operations in industry.
Submit your inquiry and a member of the scientific team will respond promptly.